HealthAssure
HealthAssureGood Life
LOINCActive

LOINC Code 62951-9: PhenX - assessment of functional gastrointestinal disorders - adult protocol 190101

62951-9 is a LOINC code used to identify PhenX - assessment of functional gastrointestinal disorders - adult protocol 190101 in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component PhenX - assessment of functional gastrointestinal disorders - adult protocol 190101. It is commonly used with the system or sample type ^Patient.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component PhenX - assessment of functional gastrointestinal disorders - adult protocol 190101. It is commonly used with the system or sample type ^Patient.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Method: PhenX

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

PhenX - assessment of functional gastrointestinal disorders - adult protocol 190101
This questionnaire is based on the Rome III symptoms-based diagnostic criteria for the functional gastrointestinal disorders (FGIDs). It can be self-administered and takes about 15 minutes to complete. Response formats for questions include yes/no responses, a five-point ordinal response scale for conditional questions (never or rarely to always), a seven-point ordinal response scale for frequency questions (never to every day), and a few other response scales specific to an item not fitting these (e.g., questions 76, 77, and 79). A series of "red flag" or alarm symptom questions are included at the end of the questionnaire (questions 82 to 93). Although these are not part of the diagnostic criteria, they are helpful in determining whether other diagnostic studies are needed to exclude other conditions/diseases that may explain symptoms captured in this questionnaire. A positive answer to any of these questions suggests a possibility of a diagnosis other than functional gastrointestinal disorder. This questionnaire (with its coding system) is intended for research and may be used to aid diagnosis. However, it is not meant as an instrument for self-diagnosis nor does it obviate the need for medical evaluation including history, physical examination, and limited laboratory and endoscopic testing of individual patients. The questionnaire is followed by a coding system that identifies provisional (or possible) diagnoses from the responses to the questions. The presence of an "alarm" symptom does not negate a diagnosis of an FGID, but it may indicate further inquiry or testing to rule out other conditions/diseases. Similarly, an indication of psychosocial difficulties will not alter the diagnosis but should prompt health care professionals to collect more information and possibly offer appropriate treatment. In the absence of biological markers and confirmatory tests for FGIDs, their diagnosis depends on applying these criteria, performing limited testing, and judiciously excluding other conditions/diseases (e.g., with other studies). Because there are no available tests to confirm the diagnosis of functional gastrointestinal disorders (FGIDs), the Gastrointestinal Working Group suggests that limited investigation be performed to exclude other conditions/diseases that may explain the reported gastrointestinal (GI) symptoms. These should include complete blood count, erythrocyte sedimentation rate and/or C-reactive protein, electrolytes, and liver function tests. In addition, it is recommended that serology for celiac sprue be completed for patients with diarrhea, a colonoscopy be completed for patients aged 50 years old or older with functional bowel symptoms, and an upper endoscopy be completed for patients aged 50 or older with upper GI symptoms. Additional tests should be considered based on presence of alarm symptom and clinical judgment of the provider. Many clinical scientists may prefer to study only one or a few of the FGIDs. To serve such a purpose, the questionnaire may be subdivided into question and coding modules for each of the disorders of interestesophageal, gastroduodenal, gallbladder/sphincter of Oddi, bowel, chronic abdominal pain, and anorectal disorders.
Assess func GI disorders adult proto; GI; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

PhenX - assessment of functional gastrointestinal disorders - adult protocol 190101Assess func GI disorders adult protoPANEL.PHENX-Pt^PatientPhenX

Frequently asked questions

Code details

Code62951-9
SystemLOINC
Display namePhenX - assessment of functional gastrointestinal disorders - adult protocol 190101
Short nameAssess func GI disorders adult proto
ComponentPhenX - assessment of functional gastrointestinal disorders - adult protocol 190101
Property-
TimingPt
System (specimen)^Patient
Scale-
MethodPhenX
ClassPANEL.PHENX
StatusACTIVE

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.36
Last changed2.81

Part names

PhenX - assessment of functional gastrointestinal disorders - adult protocol 190101-Pt^PatientPhenXPoint in time (spot)

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.